Pain management with Intrathecal clonidine in a colon cancer patient with Opioid hyperalgesia: Case presentation

Agri

Volumn 26, Issue 2, 2014, Pages 93-96

  Pirbudak, Lütfiye ^a   Sevinç, Alper ^a   Maralcan, Göktürk ^a   Kiliç, Ertuǧrul ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Cancer pain; Clonidine; Hyperalgesia; Opioids

Indexed keywords

ANALGESIC AGENT; CLONIDINE;

ADULT; CASE REPORT; COLON TUMOR; DIFFERENTIAL DIAGNOSIS; HUMAN; INTRASPINAL DRUG ADMINISTRATION; MALE; PAIN MEASUREMENT; PAIN, INTRACTABLE; VASCULAR ACCESS DEVICE;

ADULT; ANALGESICS; CLONIDINE; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INJECTIONS, SPINAL; MALE; PAIN MEASUREMENT; PAIN, INTRACTABLE; VASCULAR ACCESS DEVICES;

EID: 84903466828     PISSN: 13000012     EISSN: None     Source Type: Journal    
DOI: 10.5505/agri.2014.37233     Document Type: Article

References (18)

1. Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009;12(3):679-84.
2. Kapural L, Kapural M, Bensitel T, Sessler DL. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements. Pain Physician 2010;13(4):389-94.
3. Bannister K, Dickenson AH. Opioid hyperalgesia. Curr Opin Support Palliat Care 2010;4(1):1-5.
4. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14(2):145-61.
5. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010;363(21):1981-5.
6. Feng X, Zhang F, Dong R, Li W, Liu J, Zhao X, et al. Intrathecal administration of clonidine attenuates spinal neuroimmune activation in a rat model of neuropathic pain with existing hyperalgesia. Eur J Pharmacol 2009;614(1-3):38-43.
7. Albutt C. On the abuse of hypodermic injections of morphia. Practitioner 1870;5:327-31.
8. Rossbach M. Ueber die Gewoehnung an Gifte. Pflugers Arch Gesamte Physiol Menschen 1880;21:213-25.
9. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010;13(5):401-35.
10. Vorobeychik Y, Chen L, Bush MC, Mao J. Improved opioid analgesic effect following opioid dose reduction. Pain Med 2008;9(6):724-7.
11. Goldberg ME, Torjman MC, Schwartzman RJ, Mager DE, Wainer IW. Pharmacodynamic profiles of ketamine (R) - and (S) - with 5-day inpatient infusion for the treatment of complex regional pain syndrome. Pain Physician 2010;13(4):379-87.
12. Axelrod DJ, Reville B. Using methadone to treat opioidinduced hyperalgesia and refractory pain. J Opioid Manag 2007;3(2):113-4.
13. Chung KS, Carson S, Glassman D, Vadivelu N. Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia. Conn Med 2004;68(9):547-9.
14. Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 2005;115(3):284-95.
15. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schüttier J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003;99(1):152-9.
16. Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Ossipov MH, Lai J, et al. Production of paradoxical sensory hypersensitivity by alpha 2-adrenoreceptor agonists. Anesthesiology 2004;100(6):1538-44.
17. Romero-Sandoval A, Eisenach JC. Perineural clonidine reduces mechanical hypersensitivity and cytokine production in established nerve injury. Anesthesiology 2006;104(2):351-5.
18. De Kock M, Lavand'homme P, Waterloos H. The short-lasting analgesia and long-term antihyperalgesic effect of intrathecal clonidine in patients undergoing colonic surgery. Anesth Analg 2005;101(2):566-72.